Renal pharmacology Flashcards
what type of transport happnes for the following:
sodium (angiotensin 2), phosphate (PTH and VitD), amino acids, glucose
active reabsorption
glucose and amino acids are co-transported
what items are passivly transported?
H2O, urea and cl
list the location of SGLT1 and 2
- SGLT
- 10% of the glucose reabsorption
- SGLT
- 90% of the glucose reabsorption
- targeted for diabetics
what targets sodium-glucose transporter 2?
- mech
- side effects
- contradiction
4.
canagliflozin
- mech
- inhibitor of sodium-glucose co-transporter 2
- blocks reabsorption of glucose in the PCT
- leads to a net loss of glucose
- inhibitor of sodium-glucose co-transporter 2
- side effects
- genital mycotic infections
- thirst (dry mouth, polydipsia)
- contraindication
- severe renal impairment, end stage renal disease, dialysis
- precautions
- hypovolemia
- eGFR less than 60
- hypoglycemia
elderly patient with type two diabetes wants to take canagliflozin. What is the mech and contraincication
inhibitor of SGLT2
- contraindication
- kidney disease
-
hypovolemia
- the medication needs a certain amount of pressure to be affective
inhibit the cotransport of NKCC in lumenal membrane
furosemide (lasix)
- mech
- inhibits the cotransporter of NKCC
- affects
- more water retained in lumen dur to decreased osmotic pressure
- more efficacious than blocking Na pumps in the PCT, b/c downstream sites cannot compenstate for Na loss
- lose potasium
- adverse
- hypovolemia
- ototoxicity
- K+ depletion
where are most drugs secreted into the lumen? (not filtration)
Distal tubule
inhibit Na/Cl cotransporter on the lumenal membran of the distal tubule
- name
- affect
- vascular
thiazides
- affect
- increased excretion of Na+ and Cl- in tubular fluid
- loss of K+
- reduced peripheral vascular resistance
patient has hypertension and needs to reduce vascular resistance. Which drug will be the best fit for him?
thiazides
- mech
- inhibit Na/Cl- cotransporter on the lumenal membrane
- increased excretion of Na+ and Cl- in tubular fluid
- leads to
- loss in K+
- reduced peripheral vascular resistance
- most used class
compared to furosemide(NKCC blocker)- leading to excessive water loss
a patient administered aldosterone should be monitored for?
loss of potasium
What are the proper tests and why for the following
- central diabetes insipidus
- nephrogenic diabetes insipidus
both present with 1- hypernaturemia, polyuria, excessive thirst, and hypotonic urine
- central diabetes insipidus
- lack of antidiuretic hormone
- responds to ADH administration by increasing urine osmolality
- this then makes less urine
- lack of antidiuretic hormone
- nephrogenic diabetes insipidus
- collecting tubules are refractory to ADH
- Does not respond to ADH
- causes = drug use
- collecting tubules are refractory to ADH
You want to know what type of diabetes a patient has what test and results could you expect
adh test
- central diabetes insipidus
- respond to ADH
- generating hyperosmotic urine
- decreasing plasma osmolality
- respond to ADH
- nephrogenic diabetes
- collecting tubules are refractory to ADH
- do not respond to ADH
- lack the receptor to increase the aquaporins on the lumenal side
- collecting tubules are refractory to ADH
hyponatremia is a side effect of what type of drugs?
- depletional
- your not getting enough sodium in the body
- dilutional- SIADH
- something leads to the increase in ADH secretion
- associated with drugs
- thiazides
- antidepressants
- SSRIs
- TCA(tri-cyclic antidepressants)
- lithium
a patient experiences a significant weight gain and blood work shows the Na concentration is 80 (norm:>136mEq/L)